KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EPS (Basic) (2016 - 2025)

Zimmer Biomet Holdings has reported EPS (Basic) over the past 17 years, most recently at $0.71 for Q4 2025.

  • Quarterly results put EPS (Basic) at $0.71 for Q4 2025, down 40.83% from a year ago — trailing twelve months through Dec 2025 was $3.57 (down 19.78% YoY), and the annual figure for FY2025 was $3.56, down 20.0%.
  • EPS (Basic) for Q4 2025 was $0.71 at Zimmer Biomet Holdings, down from $1.17 in the prior quarter.
  • Over the last five years, EPS (Basic) for ZBH hit a ceiling of $2.02 in Q4 2023 and a floor of -$0.35 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was $0.88 (2022), compared with a mean of $0.82.
  • Biggest five-year swings in EPS (Basic): tumbled 111.8% in 2021 and later soared 1485.71% in 2023.
  • Zimmer Biomet Holdings' EPS (Basic) stood at -$0.19 in 2021, then plummeted by 84.21% to -$0.35 in 2022, then surged by 677.14% to $2.02 in 2023, then crashed by 40.59% to $1.2 in 2024, then crashed by 40.83% to $0.71 in 2025.
  • The last three reported values for EPS (Basic) were $0.71 (Q4 2025), $1.17 (Q3 2025), and $0.77 (Q2 2025) per Business Quant data.